"onconeuronal" meaning in All languages combined

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "onco",
        "3": "neuronal"
      },
      "expansion": "onco- + neuronal",
      "name": "prefix"
    }
  ],
  "etymology_text": "From onco- + neuronal.",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "onconeuronal (not comparable)",
      "name": "en-adj"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "adj",
  "senses": [
    {
      "categories": [
        {
          "kind": "other",
          "name": "English entries with incorrect language header",
          "parents": [
            "Entries with incorrect language header",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms prefixed with onco-",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "Pages with 1 entry",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "Pages with entries",
          "parents": [],
          "source": "w"
        }
      ],
      "examples": [
        {
          "ref": "2016 January 16, “Effect of Immunotherapy on Seizure Outcome in Patients with Autoimmune Encephalitis: A Prospective Observational Registry Study”, in PLOS ONE, →DOI:",
          "text": "Because the majority of patients had either anti-NMDAR or -VGKC antibodies, autoantibody type was categorized into the following three groups: anti-NMDAR, anti-VGKC (LGI1 or Capsr2), and others (anti-GABAb or onconeuronal antibody).",
          "type": "quote"
        }
      ],
      "glosses": [
        "Related to cancer and to neurological syndromes"
      ],
      "id": "en-onconeuronal-en-adj-6uTHrvDB",
      "links": [
        [
          "cancer",
          "cancer"
        ],
        [
          "neurological",
          "neurological"
        ]
      ],
      "tags": [
        "not-comparable"
      ]
    }
  ],
  "word": "onconeuronal"
}

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "onco",
        "3": "neuronal"
      },
      "expansion": "onco- + neuronal",
      "name": "prefix"
    }
  ],
  "etymology_text": "From onco- + neuronal.",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "onconeuronal (not comparable)",
      "name": "en-adj"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "adj",
  "senses": [
    {
      "categories": [
        "English adjectives",
        "English entries with incorrect language header",
        "English lemmas",
        "English terms prefixed with onco-",
        "English terms with quotations",
        "English uncomparable adjectives",
        "Pages with 1 entry",
        "Pages with entries"
      ],
      "examples": [
        {
          "ref": "2016 January 16, “Effect of Immunotherapy on Seizure Outcome in Patients with Autoimmune Encephalitis: A Prospective Observational Registry Study”, in PLOS ONE, →DOI:",
          "text": "Because the majority of patients had either anti-NMDAR or -VGKC antibodies, autoantibody type was categorized into the following three groups: anti-NMDAR, anti-VGKC (LGI1 or Capsr2), and others (anti-GABAb or onconeuronal antibody).",
          "type": "quote"
        }
      ],
      "glosses": [
        "Related to cancer and to neurological syndromes"
      ],
      "links": [
        [
          "cancer",
          "cancer"
        ],
        [
          "neurological",
          "neurological"
        ]
      ],
      "tags": [
        "not-comparable"
      ]
    }
  ],
  "word": "onconeuronal"
}